Announcements Trials
Browse Landscape

Phase

Phase NA 30Phase 2 4Phase 1/2 3Phase 1 3Phase 4 2Phase 3 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 592Neoplasms 296Carcinoma, Non-Small-Cell Lung 284Prostatic Neoplasms 266Colorectal Neoplasms 213Multiple Myeloma 181Lung Neoplasms 149Neoplasm Metastasis 139Leukemia, Myeloid, Acute 125Leukemia 120Lymphoma 114Lymphoma, Follicular 113Stomach Neoplasms 105Lymphoma, Non-Hodgkin 102Colonic Neoplasms 98Ovarian Neoplasms 96Rectal Neoplasms 95Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Uterine Cervical Neoplasms 93Head and Neck Neoplasms 92Leukemia, Lymphocytic, Chronic, B-Cell 91Pain 90Carcinoma, Hepatocellular 86Pancreatic Neoplasms 81Melanoma 78Lymphoma, Large B-Cell, Diffuse 77Papillomavirus Infections 68Recurrence 66Squamous Cell Carcinoma of Head and Neck 64Parkinson Disease 4, Autosomal Dominant Lewy Body 62

Interventions

Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Completed × Smoking × Clear all
NCT02267096 2016-10-19

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

Georgetown University

Phase 3 Completed
95 enrolled
Thoracic

Lung Neoplasms, Smoking

NCT00981201 2012-08-01

Celecoxib as a Chemopreventive Agent in Current and Former Smokers

M.D. Anderson Cancer Center

Phase 3 Completed
219 enrolled

Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡